Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 1997

View Archived Issues

Company Profile: Pentose

Vitamin D analogue undergoes phase I evaluation for osteoporosis

Company Profile: Cubist Pharmaceuticals

Astra Merck and P&G to develop OTC formulation of Prilosec for heartburn

Glaucoma diagnostic technology covered by U.S. patent

Bard to distribute ProCyte's wound care products

Neovascularization inhibitors from Tsumura Juntendo

Farnesyltransferase inhibitors claimed by Banyu

Dainippon discloses new H+/K+-ATPase inhibitors

Sumitomo synthesizes new series of ECE inhibitors

FA-70D: a new cathepsin inhibitor from Taiho

New dihydropyridine derivatives with cardiovascular activity from Mercian

Toa Eiyo discovers new anti-H. pylori agents

Burzynski's antineoplastons in phase II testing for multiple oncology indications

Singulair available in Mexico for asthma

Biora in-licenses new protein for dental applications

Phase II trial of Vasoflux begins in acute MI

La Jolla evaluates Toleragan compounds for xenotransplantation

Millennium/Pfizer antifungal collaboration expanded

LJP-394 binds to B-cells in lupus patients

Seragen reports preliminary results of pivotal CTCL study

LifeCell's ThromboSol to enter clinical feasibility study

Clinical evaluation of adenoviral-p53 gene therapy for prostate cancer begins

Antidiabetic drug research at Takeda

Indomethacin: antitumor activity and effects on telomerase

Z-103 as effective as sulfasalazine in rat model of colitis

First U.S. trials of Zemaphyte to begin

Once-daily tacalcitol vs. twice-daily calcipotriol for chronic plaque psoriasis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...